Clinical Trial Details
— Status: Recruiting
Administrative data
NCT number |
NCT05388578 |
Other study ID # |
P21.113 |
Secondary ID |
|
Status |
Recruiting |
Phase |
|
First received |
|
Last updated |
|
Start date |
July 7, 2022 |
Est. completion date |
July 1, 2023 |
Study information
Verified date |
August 2022 |
Source |
Leiden University Medical Center |
Contact |
Hermes AJ Spaink, MSc |
Phone |
+31 71 5262 547 |
Email |
h.a.j.spaink[@]lumc.nl |
Is FDA regulated |
No |
Health authority |
|
Study type |
Observational
|
Clinical Trial Summary
Although there have been major advances in (personalized) stroke treatment in the last
decade, the need for prevention of stroke remains critical. Prevention of recurrent stroke is
currently primarily organized through management of cardiovascular risk factors including
lifestyle, hypertension and atrial fibrillation (AF). To improve the cardiovascular risk
management of stroke patients, more frequent measurements of blood pressure and heart rhythm
are essential. In addition, actively engaging the patient with their own recovery could lead
to an improved lifestyle. Recent studies have shown telemonitoring of patients can improve
care, help with prevention of disease, and reduce healthcare costs, whilst keeping the
patient more engaged with their disease.
The LUMC "Box" has shown to effectively monitor blood pressure of patients after myocardial
infarction with equal results and patient satisfaction rates compared to standard care with
less physical contact moments. We plan to use this framework for improving post-stroke care
by introducing more frequent blood pressure and heart rhythm measurements. Additionally, we
will provide more information around lifestyle improvement and have the patient actively
engage with their weight and physical activity.
In this study we will be evaluating the technical feasibility and clinical implementation of
the home-based self-measurements using the Box in a post-stroke pilot setting: the Stroke
Box. The results will be used as a basis for the power calculation for a future randomized
clinical trial on the effect of the BOX on hypertension treatment and AF detection.
Description:
Objective: The overall aim of this pilot is to evaluate the technical feasibility and
clinical implementation of the Stroke Box by evaluating user experience and hypertension
management. The primary objective is gathering data on blood pressure management for power
calculation for a future randomized clinical trial where the effect of the Stroke Box on
hypertension management and AF detection will be studied. The secondary objectives will be
gathering and evaluating data on heart rhythm, weight and activity of patients using the
Stroke Box, evaluating the technical- and workflow implementation for healthcare
professionals, evaluating the self-management and user-experience of patients, assessing the
patient adherence to the self-measurements and pharmacotherapeutic prophylactic therapy, and
evaluating the correct functioning of the IT infrastructure, hardware and LUMC Care app, and
to assess the correct use of all stakeholders involved in the eHealth support and
telemonitoring with the Stroke Box.
Study design: This study is a prospective cohort study to evaluate the implementation of the
Stroke Box and gather data. For the first 5 patients we will mainly evaluate the technical
procedures of the study in addition to the other objectives. For the remainder, we will be
gathering data on blood pressure management, patient engagement and have a user-based
evaluation of the eHealth infrastructure during a six-month follow-up period. We will do
evaluations of the collected data based on a before-after comparison of blood pressure and
questionnaire results.
Study population: Patients admitted for a TIA, ischemic or haemorrhagic stroke in the LUMC.
We will include 55 patients in total of which in the first 5 patients we specifically focus
on testing and evaluating the technical feasibility.
Intervention (if applicable): The Stroke Box will contain a blood pressure monitor, weighting
scale, single-lead ECG wristwatch with activity tracking and associated apps. Patients are
asked to measure the associated factors on a daily basis. In addition, all patients will be
asked to fill in a questionnaire at the start and the end of the study. Patients will
participate for 6 months in the pilot.
Main study parameters/endpoints: The primary objective of this study is the gathering of data
on blood pressure management as a basis for power analysis in future trials. The secondary
objectives will be gathering and evaluating data on heart rhythm, weight and activity of
patients, evaluating the technical- and workflow implementation for healthcare professionals,
evaluating the self-management and user-experience of patients, assessing the patient
adherence to the self-measurements and pharmacotherapeutic prophylactic therapy, and finally
evaluating the technical feasibility for all stakeholders.